Adage Capital Partners’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-663,546
Closed -$17.5M 1084
2025
Q4
$17.5M Buy
663,546
+99,546
+18% +$2.17M 0.03% 539
2025
Q3
$9.63M Buy
564,000
+88,000
+18% +$1.26M 0.02% 638
2025
Q2
$5.97M Buy
+476,000
New +$5.67M 0.01% 686

Other funds holding ZYME

Adage Capital Partners's ZYME Position: Q1 2026 in Review

Adage Capital Partners sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 663,546 shares — an estimated $17.5M sold.

Adage Capital Partners first reported a position in ZYME in Q2 2025 and held it in 3 quarters. The position peaked at $17.5M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Adage Capital Partners reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Adage Capital Partners sold 663,546 Zymeworks shares in Q1 2026, an estimated $17.5M.
  • Adage Capital Partners first reported a position in Zymeworks in Q2 2025 and held it in 3 quarters.
  • Adage Capital Partners's Zymeworks position peaked at $17.5M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.